Merck & Co., Inc. – Corporate Update
Trading Activity
Stock Performance
Merck & Co. (ticker: MRK) closed the trading session on Friday, 23 March 2026, down 1.76 % at 07:34 PM Central Europe.
The most recent 24‑hour trading volume was approximately USD 2.8 bn.
The current price on major exchanges is USD 144.89.
Market capitalization stands at USD 369.8 bn.
The 200‑day simple moving average is USD 125.68.
The highest price in the last 52 weeks was USD 156.92 on 25 August 2026; the lowest was USD 82.01 on 4 November 2025.
From the end of the previous month to the present, the share price has declined 0.57 %.
Shares Outstanding
The company has 2.5 bn shares available for trading.
Recent Corporate Development
Merck & Co. announced progress in its collaboration with Moderna on a personalized messenger RNA (mRNA) vaccine targeting melanoma. The Phase III INTerpath‑001 study enrolled over 1,000 patients with resected high‑risk melanoma. Key findings include:
- A clinically meaningful reduction in tumour recurrence and mortality.
- When combined with KEYTRUDA, the vaccine lowered rates of recurrence and distant metastasis.
- Safety data presented at the European Society for Medical Oncology congress confirmed an acceptable safety profile.
- The results support the vaccine’s continued development across multiple tumour types.
Analysts noted that, while the efficacy data are positive, they may not fully satisfy the high expectations set by earlier preliminary reports.
Market Context – Related Stocks
| Company | Recent Performance | Current Price | Market Cap (bn USD) | P/E Ratio |
|---|---|---|---|---|
| Caterpillar (CAT) | Down 4.89 % | 686.57 | 340.3 | 31.84 |
| Bank of America (BAC) | Up 0.59 % | 50.62 | 351.5 | 12.21 |
| Coca‑Cola (KO) | Up 2.87 % | 92.92 | 398.8 | 27.92 |
| Costco Wholesale (COST) | Up 1.99 % | 1,005.60 | 442.4 | 48.09 |
| UnitedHealth (UNH) | Up 1.91 % | 420.32 | 374.3 | 23.80 |
- Caterpillar is preparing for an earnings report this week; market focus is on capital‑spending guidance amid tightening monetary policy.
- Bank of America filed a free‑writing prospectus under Securities Act Rules 163/433, providing updated corporate information without financial metrics.
- Coca‑Cola announced a revision of its plastic‑packaging advertising to comply with EU consumer‑protection regulations, removing unverified claims about bottle recyclability.
- Costco Wholesale highlighted CEO Ron Vachris’s career progression from entry‑level operations to executive leadership, emphasizing internal talent development.
- UnitedHealth showed modest share gains, reflecting broader healthcare market stability.
Company Overview
Merck & Co., Inc. is a global healthcare company that develops and markets prescription medicines, vaccines, biologic therapies, animal health products, and consumer care items. Its portfolio is distributed directly to consumers and through joint ventures, positioning the company as a significant player in both pharmaceutical and consumer health markets.
